An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial. - Connolly, M; Nielsen, S; Currie, C; Poole, C; Travis, S (Journal of Crohn's and colitis, 2009)